Emergent Stock Volatility


USD 20.99  0.43  2.01%   

Emergent Biosolutions secures Sharpe Ratio (or Efficiency) of -0.18, which denotes the company had -0.18% of return per unit of risk over the last 3 months. Macroaxis standpoint towards predicting the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Emergent Biosolutions exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Emergent Biosolutions coefficient of variation of (649.90), and Mean Deviation of 2.58 to check the risk estimate we provide.
Emergent Biosolutions Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Emergent daily returns, and it is calculated using variance and standard deviation. We also use Emergent's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Emergent Biosolutions volatility.

30 Days Market Risk

Not too volatile

Chance of Distress

Below Average

30 Days Economic Sensitivity

Actively responds to the market
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Emergent Biosolutions can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Emergent Biosolutions at lower prices. For example, an investor can purchase Emergent stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Emergent Biosolutions' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Emergent Biosolutions

+0.74MKGAFMerck Kgaa DmPairCorr
+0.76MKKGYMerck Kgaa ADRPairCorr
+0.84TKPHFTakeda PharmaceuticaPairCorr
+0.92TAKTakeda PharmaceuticalPairCorr
+0.68HLNHaleon PlcPairCorr

Moving against Emergent Biosolutions

-0.8RUMRumble IncPairCorr
-0.51SBUXStarbucks Corp Fiscal Year End 27th of October 2022 PairCorr

Emergent Biosolutions Market Sensitivity And Downside Risk

Emergent Biosolutions' beta coefficient measures the volatility of Emergent stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Emergent stock's returns against your selected market. In other words, Emergent Biosolutions's beta of 1.65 provides an investor with an approximation of how much risk Emergent Biosolutions stock can potentially add to one of your existing portfolios.
Emergent Biosolutions exhibits very low volatility with skewness of -0.14 and kurtosis of 1.48. However, we advise investors to further study Emergent Biosolutions technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Emergent Biosolutions' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Emergent Biosolutions' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
3 Months Beta |Analyze Emergent Biosolutions Demand Trend
Check current 90 days Emergent Biosolutions correlation with market (DOW)

Emergent Beta

Emergent standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

It is essential to understand the difference between upside risk (as represented by Emergent Biosolutions's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Emergent Biosolutions' daily returns or price. Since the actual investment returns on holding a position in emergent stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Emergent Biosolutions.

Using Emergent Put Option to Manage Risk

Put options written on Emergent Biosolutions grant holders of the option the right to sell a specified amount of Emergent Biosolutions at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Emergent Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Emergent Biosolutions' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Emergent Biosolutions will be realized, the loss incurred will be offset by the profits made with the option trade.

Emergent Biosolutions' PUT expiring on 2022-10-21

       Emergent Biosolutions Price At Expiration  

Current Emergent Biosolutions Insurance Chain

DeltaGammaOpen IntExpirationCurrent SpreadLast Price
2022-10-21 PUT at $35.0-0.65050.025612022-10-2111.0 - 16.014.63View
2022-10-21 PUT at $30.0-0.61780.0311112022-10-216.1 - 11.07.0View
2022-10-21 PUT at $25.0-0.75710.0756212022-10-212.7 - 4.14.2View
2022-10-21 PUT at $22.5-0.59210.117232022-10-211.6 - 2.31.8View
2022-10-21 PUT at $20.0-0.30070.10351602022-10-210.55 - 0.851.0View
View All Emergent Biosolutions Options

Emergent Biosolutions Stock Volatility Analysis

Volatility refers to the frequency at which Emergent Biosolutions stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Emergent Biosolutions' price changes. Investors will then calculate the volatility of Emergent Biosolutions' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Emergent Biosolutions' volatility:

Historical Volatility

This type of stock volatility measures Emergent Biosolutions' fluctuations based on previous trends. It's commonly used to predict Emergent Biosolutions' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Emergent Biosolutions' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Emergent Biosolutions' to be redeemed at a future date.
The output start index for this execution was zero with a total number of output elements of sixty-one. The Median Price line plots median indexes of Emergent Biosolutions price series.

Emergent Biosolutions Projected Return Density Against Market

Considering the 90-day investment horizon the stock has the beta coefficient of 1.6542 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Emergent Biosolutions will likely underperform.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Emergent Biosolutions or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Emergent Biosolutions' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Emergent stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Emergent Biosolutions is significantly underperforming DOW.
   Predicted Return Density   
Emergent Biosolutions' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how emergent stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Emergent Biosolutions Price Volatility?

Several factors can influence a Stock's stock volatility:


Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Emergent Biosolutions Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Emergent Biosolutions or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Emergent Biosolutions' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Emergent stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. Considering the 90-day investment horizon the coefficient of variation of Emergent Biosolutions is -544.11. The daily returns are distributed with a variance of 12.28 and standard deviation of 3.5. The mean deviation of Emergent Biosolutions is currently at 2.57. For similar time horizon, the selected benchmark (DOW) has volatility of 1.23
Alpha over DOW
Beta against DOW1.65
Overall volatility
Information ratio -0.14

Emergent Biosolutions Stock Return Volatility

Emergent Biosolutions historical daily return volatility represents how much of Emergent Biosolutions stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The enterprise has volatility of 3.5036% on return distribution over 90 days investment horizon. By contrast, DOW inherits 1.2493% risk (volatility on return distribution) over the 90 days horizon.
 Performance (%) 

About Emergent Biosolutions Volatility

Volatility is a rate at which the price of Emergent Biosolutions or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Emergent Biosolutions may increase or decrease. In other words, similar to Emergent's beta indicator, it measures the risk of Emergent Biosolutions and helps estimate the fluctuations that may happen in a short period of time. So if prices of Emergent Biosolutions fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats in the United States. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland. Emergent Biosolutions operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 2416 people.

Emergent Biosolutions Investment Opportunity

Emergent Biosolutions has a volatility of 3.5 and is 2.8 times more volatile than DOW. 30  of all equities and portfolios are less risky than Emergent Biosolutions. Compared to the overall equity markets, volatility of historical daily returns of Emergent Biosolutions is lower than 30 () of all global equities and portfolios over the last 90 days. Use Emergent Biosolutions to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Emergent Biosolutions to be traded at $20.15 in 90 days.

Very weak diversification

The correlation between Emergent Biosolutions and DJI is 0.58 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and DJI in the same portfolio, assuming nothing else is changed.

Emergent Biosolutions Additional Risk Indicators

The analysis of Emergent Biosolutions' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Emergent Biosolutions' investment and either accepting that risk or mitigating it. Along with some common measures of Emergent Biosolutions stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Emergent Biosolutions Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Emergent Biosolutions as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Emergent Biosolutions' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Emergent Biosolutions' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Emergent Biosolutions.
Continue to Investing Opportunities. Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Emergent Stock analysis

When running Emergent Biosolutions price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine Emergent Biosolutions value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.